PHASE III STUDY

the third and final clinical trial of an experimental drug. This third stage in a new drug's approval process expandes the test to several thousand volunteers. The purpose is to evaluate the drug in a larger population to make sure the results of the first two phases hold true in a larger base. Problems involving drug interactions commonly surface during this third stage. Phase II clinical trials are part of the U.S. FDA approval process.